Veículo
Wion News
Em 2025: 0 notícias
Desde 1995: 4 notícias
Sarah Gilbert, creator of Oxford-AstraZeneca Covid vaccine, gets her own Barbie doll
Publicado em 04 agosto 2021
The co-creator of the Pfizer-AstraZeneca coronavirus vaccine is set to be part of the Barbie dolls for her achievement that has saved millions around the world from the deadly coronavirus.
Professor Sarah Gilbert led the development of the AstraZeneca-Oxford vaccine at Oxford University. She had earlier been thanked for her efforts at the Wimbledon in form of a standing ovation, she has been made a dame and now, she has a Barbie doll made in her honour.
Gilbert, however, says she found this [...]
-
COVID-19 can infect, replicate in salivary gland cells; serve as reservoirs for viruses
Publicado em 08 julho 2021The infectivity of the SARS-CoV-2 coronavirus has been surprising the scientific world as the COVID-19 epidemic has proceeded. While the virus mostly affects the lungs, it has been discovered to infect other organs as well. The heart, kidneys, stomach, and eyes are among the organs affected. Scientists have found that this dangerous disease may infect and replicate within the salivary glands. Brazilian researchers discovered that saliva-producing and secreting tissues can act as reservoirs [...]ver notícia -
Virus variant in Brazil infected many who had already recovered from Covid-19
Publicado emIn just a matter of weeks, two variants of the coronavirus have become so familiar that you can hear their inscrutable alphanumeric names regularly uttered on television news. B.1.1.7, first identified in Britain, has demonstrated the power to spread far and fast. In South Africa, a mutant called B.1.351 can dodge human antibodies, blunting the effectiveness of some vaccines. Scientists have also had their eye on a third concerning variant that arose in Brazil, called P.1. Research had been [...]ver notícia -
Epigenetic modulators have a rapid antidepressant-like effect, study shows
Publicado em 04 janeiro 2021The treatment of depression faces two main challenges. The first is that almost 50% of patients do not respond well to existing antidepressants. The second is that conventional drugs take relatively long – about three to five weeks – to have the desired effect. A group of researchers affiliated with the University of São Paulo (USP) in Brazil set out to address the second problem using epigenetic modulators to try to “erase” the consequences of stress. Epigenetic [...]ver notícia